Cellular Longevity Protocol

NAD+ Therapy Online: At-Home Subcutaneous Protocols

Starting NAD+ therapy online through Losing Weight RX pairs a licensed US clinician review with 503A pharmacy-compounded vials delivered directly to your door with $0 membership fees. Restore declining NAD+ levels with injectable therapy — bypassing oral supplement limitations for superior bioavailability. Boost energy, clarity, and cellular repair.

$69/mo · all-inclusive
No Insurance NeededHSA/FSA EligibleFree Shipping
NAD+ injectable therapy vial
Simple Process

How to get NAD+ therapy prescribed online

From assessment to delivery in as few as 4 days. No office visits required.

Step 1

Complete online assessment

Answer a 5-minute health questionnaire covering your medical history, current supplements, and longevity goals.

Step 2

Provider review & prescription

A licensed provider evaluates your profile and prescribes NAD+ therapy if clinically appropriate for your health goals.

Step 3

NAD+ shipped to your door

Your injectable NAD+ is compounded by a licensed pharmacy and shipped express directly to your door.

Why choose injectable NAD+ therapy

Restore the coenzyme your cells need for energy, repair, and longevity.

Cellular Energy Restoration

NAD+ is a critical coenzyme in every cell. Levels decline 50% by age 50. Supplementation restores mitochondrial function and cellular energy production.

$99/mo All-Inclusive

Medication, provider consultation, and free express shipping included. No hidden fees. Compare to IV NAD+ clinics at $500–$1,000+ per session.

Cognitive Clarity & Focus

NAD+ supports neuronal health and neurotransmitter production. Patients report improved mental clarity, focus, and reduced brain fog within weeks.

Anti-Aging & Recovery

NAD+ activates sirtuins (longevity proteins) and supports DNA repair. May improve sleep quality, exercise recovery, and overall vitality.

The science behind NAD+

A coenzyme essential for 500+ enzymatic reactions, actively researched at leading academic institutions worldwide.

500+
Enzymatic reactions dependent on NAD+ in every cell
50%
Decline in NAD+ levels between ages 40–60
7
Sirtuin longevity proteins activated by NAD+

How NAD+ therapy works

NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme found in every living cell, essential for converting food into cellular energy and regulating critical biological processes.

  • Powers ATP production — the primary energy currency of your cells via mitochondrial function
  • Activates sirtuins — a family of proteins linked to longevity and cellular repair across species
  • Supports DNA repair — essential for maintaining genomic integrity as cells age
  • Superior bioavailability — injectable delivery bypasses digestive breakdown unlike oral NMN/NR supplements

Transparent, all-inclusive pricing

No hidden fees. No surprise charges. Everything included.

Longevity Protocol
Cellular Longevity
Compounded NAD+
$69
per month · all-inclusive starting price
  • Injectable NAD+ protocol
  • Licensed provider consultation
  • Custom compounding by licensed pharmacy
  • Free express shipping
  • No membership fees
  • HSA/FSA eligible
Get Started

Frequently asked questions about NAD+ therapy

NAD+ (Nicotinamide Adenine Dinucleotide) is a critical coenzyme found in every cell. Injectable NAD+ therapy delivers this molecule directly, bypassing digestive breakdown for superior bioavailability compared to oral supplements like NMN or NR.

NAD+ therapy is popular among adults seeking to combat age-related energy decline, improve cognitive function, support recovery from exercise, and promote overall cellular health and longevity. It's especially popular among biohackers and longevity-focused individuals.

Injectable NAD+ bypasses the digestive system, providing higher and more sustained bioavailability. Oral supplements (like NMN or NR) must be converted through multiple enzymatic steps, losing significant potency along the way.

Many patients report improved energy and mental clarity within 1–2 weeks. Optimal benefits — including improved sleep quality, recovery, and overall vitality — typically develop over 4–8 weeks of consistent use.

NAD+ is a naturally occurring molecule in your body. Compounded NAD+ injections are prepared by licensed pharmacies under strict quality controls. Side effects are generally mild and may include temporary flushing or injection site discomfort.

No. Our $99/mo pricing is all-inclusive for cash-pay patients. No insurance or prior authorization needed. HSA/FSA accepted. Compare to IV NAD+ clinics that charge $500–$1,000+ per single session.

Healthy active lifestyle

Start your NAD+ therapy
journey today

Complete your online health assessment now. If clinically appropriate, your injectable NAD+ will be compounded and shipped express to your door. $99/mo, all-inclusive.

Begin Assessment →
Open-Science Pricing & Bioavailability Verification (CC-BY-4.0) Independently benchmarked in our 2026 empirical dataset by the Losing Weight RX Pharmacoeconomics Desk.
Interactive Dataset DOI: 10.5281/zenodo.24139333 Parquet Split 2026 Audit Report

2026 Verified GLP-1 Cash-Cost & U-100 Syringe Unit Benchmark

Independent pharmacoeconomic comparison of flat-rate Section 503A compounded protocols (pure base API only, $0 monthly membership fee) versus brand-name cash list prices, paired with standard U-100 insulin syringe unit calibration.

Protocol / Active Ingredient 2026 Cash Rate Membership Fee U-100 Syringe Range Clinical Trial Reference
503A Compounded Semaglutide (Base API) $49/mo flat $0 / mo 10–96 units (2.5 mg/mL vial) STEP-1 (NEJM 2021)
503A Compounded Tirzepatide (Base API) $99/mo flat $0 / mo 12.5–75 units (20 mg/mL vial) SURMOUNT-1 (NEJM 2022)
Brand-Name Wegovy® / Zepbound® $1,086–$1,349/mo $0–$145 / mo Pre-filled auto-injector pen SELECT CVOT (NEJM 2023)
52-Week GLP-1 Cost-Per-mg Calculator → Vial mg/mL to U-100 Units Converter → 2026 Open-Data Titration Cost Dataset → View Transparent $49/$99 Flat-Rate Pricing →
Authored by Claire Bennett, M.S. · Medically Reviewed by Dr. Elena Rivera, M.D.
Last Reviewed:
FDA Boxed Warning — Risk of Thyroid C-Cell Tumors: GLP-1 and GIP/GLP-1 receptor agonists (semaglutide, tirzepatide) have caused thyroid C-cell tumors in rodent studies; human relevance has not been determined. Absolute Contraindications: Do not use if you have (1) a personal or family history of Medullary Thyroid Carcinoma (MTC), (2) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), (3) a history of acute or chronic pancreatitis, (4) active pregnancy, planned pregnancy within 2 months, or breastfeeding, or (5) a known serious hypersensitivity reaction to semaglutide, tirzepatide, or any excipient.

Section 503A Compounding & Pure Base-API Notice: Compounded medications are prepared by state-licensed U.S. Section 503A pharmacies pursuant to an individualized prescription under 21 U.S.C. § 353a and are not FDA-approved; the FDA does not review compounded drugs for safety, effectiveness, or quality. Losing Weight RX partner pharmacies strictly compound with pure base API only and prohibit FDA-unapproved salt forms (semaglutide sodium or semaglutide acetate). Consult a licensed clinician via clinical eligibility screening before starting therapy.

Clinical & Regulatory References

The clinical efficacy, dosing, safety, and regulatory information in NAD+ Therapy Online: At-Home Subcutaneous Protocols is supported by the following peer-reviewed studies and authoritative .gov / .edu sources:

  1. Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021). NAD(+) metabolism and its roles in cellular processes during ageing. Nature reviews. Molecular cell biology, 22(2), 119-141. https://doi.org/10.1038/s41580-020-00313-x
  2. Irie, J., Inagaki, E., Fujita, M., Nakaya, H., Mitsuishi, M., Yamaguchi, S., Yamashita, K., Shigaki, S., Ono, T., Yukioka, H., Okano, H., Nabeshima, Y. I., Imai, S. I., Yasui, M., Tsubota, K., & Itoh, H. (2020). Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocrine journal, 67(2), 153-160. https://doi.org/10.1507/endocrj.EJ19-0313
  3. Legal Information Institute, Cornell Law School. (2024). 21 U.S.C. § 353a — Pharmacy compounding. https://www.law.cornell.edu/uscode/text/21/353a
  4. U.S. Food and Drug Administration. (2024). Human drug compounding: Section 503A of the Federal Food, Drug, and Cosmetic Act. https://www.fda.gov/drugs/guidance-compliance-regulatory-information/human-drug-compounding
  5. U.S. Food and Drug Administration. (2025). FDA's concerns with unapproved GLP-1 drugs used for weight loss. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
  6. Yi, L., Maier, A. B., Tao, R., Lin, Z., Vaidya, A., Pendse, S., Thasma, S., Andhalkar, N., Avhad, G., & Kumbhar, V. (2023). The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience, 45(1), 29-43. https://doi.org/10.1007/s11357-022-00705-1